The recent market downturn, triggered by inflation concerns, has cast a shadow over the once-hype-filled world of tech startups. One such company, Cerebras (CBRS), has become a poster child for the perils of overvaluation and overconfidence. With a valuation of $100B+ on just two paying UAE customers, Cerebras' stock price plunged nearly 28%, serving as a stark reminder of the market's fickle nature.
The CBRS story is a cautionary tale of hubris and over-exuberance. Trading at a sky-high 134x trailing revenue, CBRS is over five times more expensive than Nvidia, a company with a proven track record of success. This valuation disparity is further exacerbated by a heavy concentration of customers and an unproven large-scale production model. The backlog, while impressive, is front-loaded with exclusivity and delay risks, meaning only 15% of it will be recognized in the next two years.
The chip sector, with its recent exuberance, has triggered a bond market vigilance that investors should heed. I recommend raising cash, monitoring the VIX, and exercising risk discipline. The market's recent downturn is a wake-up call, reminding us that hype alone is not enough to sustain a company's success. It's a lesson in humility and a reminder that the market is always right, even when it's wrong.
In my opinion, the CBRS case is a microcosm of the broader tech industry's current state. It highlights the dangers of overvaluation and the importance of a balanced approach to investing. While the market may be unforgiving, it also provides opportunities for those who are willing to learn from its lessons and adapt accordingly. As an investor, it's crucial to remain vigilant, keep an eye on the VIX, and be prepared to act when the market presents its next opportunity.
